Bank of America foresees a large increase in two high-potential biotech stocks, aided by a cooling economy that reduces inflation…
The 12th edition of The Annual Investment Meeting (AIM) hosted the China Top 50 Unicorns. The event took place at…
A more than 10% surge in growth stocks since the start of the quarter is fueling a comeback in star…
Orphazyme (ORPHA.CO) slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate, sending shares in…
Small-time stock traders turned their attention to the biotech and healthcare sectors on Monday, lifting shares of some by as…
The approval by U.S. regulators on Monday of a Biogen Inc (BIIB.O) drug to treat Alzheimer's disease could reinvigorate investor…